Related Experiment Videos
Aims and methods. LUTS suggestive of BPH
D Prezioso1, R M Scarpa, F Zattoni
1Università Federico II, Napoli, Italy.
European Urology
|October 13, 2001
Summary
This study evaluated lower urinary tract symptoms and quality of life in Italian men with benign prostatic hyperplasia (BPH). Baseline data from 1,033 patients provide insights into symptom management and patient characteristics.
Area of Science:
- Urology
- Epidemiology
- Quality of Life Research
Background:
- Limited epidemiological data exists on Italian patients experiencing lower urinary tract symptoms (LUTS) and their impact on quality of life (QoL).
- Benign prostatic hyperplasia (BPH) is a common condition affecting aging men, often associated with LUTS and reduced QoL.
Purpose of the Study:
- To conduct an observational longitudinal study (QUIBUS) evaluating symptoms and QoL in a large Italian BPH patient cohort.
- To investigate the correlation between patient characteristics (demographic, social, clinical) and BPH-related symptoms and QoL.
Main Methods:
- 1,033 Italian patients with LUTS and prostate enlargement suggestive of BPH were enrolled across 31 urology centers.
- Baseline data collected included demographics, social factors, and clinical aspects.
- Symptoms and QoL were assessed using the International Prostate Symptom Score (IPSS) and the Incontinence Quality of Life Questionnaire (IQOL) at baseline.
Main Results:
- Baseline results from 1,033 enrolled patients are presented.
- The study covers medical management, lifestyle factors, symptom severity, bothersomeness, QoL, sexual function, and uroflowmetry.
- Follow-up data after 1 year of treatment is currently under evaluation.
Conclusions:
- The QUIBUS study provides valuable baseline epidemiological data on Italian BPH patients.
- Understanding the relationship between patient characteristics and symptom/QoL outcomes is crucial for effective BPH management.
- Further analysis of follow-up data will offer insights into treatment effectiveness and long-term QoL in BPH patients.